Path ID: DB00797_MESH_D014652_1

db00797-mesh-d014652-1

Concepts

Identifier Name Type
MESH:D014043 tolazoline Drug
UniProt:P35348 Alpha-1A adrenergic receptor Protein
UniProt:P08913 Alpha-2A adrenergic receptor Protein
UniProt:P18089 Alpha-2B adrenergic receptor Protein
UniProt:P18825 Alpha-2C adrenergic receptor Protein
reactome:R-HSA-416476 G alpha (q) signalling events Pathway
reactome:R-HSA-416482 G alpha (12/13) signalling events Pathway
reactome:R-HSA-418594 G alpha (i) signalling events Pathway
reactome:R-HSA-418597 G alpha (z) signalling events Pathway
GO:0042310 vasoconstriction BiologicalProcess
MESH:D014652 Vascular Diseases Disease

Relationships

NOTE: predicates are annotated in Biolink Model (v1.3.0)

Subject Predicate Object
Tolazoline NEGATIVELY REGULATES Alpha-1A Adrenergic Receptor
Tolazoline NEGATIVELY REGULATES Alpha-2A Adrenergic Receptor
Tolazoline NEGATIVELY REGULATES Alpha-2B Adrenergic Receptor
Tolazoline NEGATIVELY REGULATES Alpha-2C Adrenergic Receptor
Alpha-1A Adrenergic Receptor PARTICIPATES IN G Alpha (Q) Signalling Events
Alpha-1A Adrenergic Receptor PARTICIPATES IN G Alpha (12/13) Signalling Events
Alpha-2A Adrenergic Receptor PARTICIPATES IN G Alpha (I) Signalling Events
Alpha-2A Adrenergic Receptor PARTICIPATES IN G Alpha (Z) Signalling Events
Alpha-2B Adrenergic Receptor PARTICIPATES IN G Alpha (I) Signalling Events
Alpha-2B Adrenergic Receptor PARTICIPATES IN G Alpha (Z) Signalling Events
Alpha-2C Adrenergic Receptor PARTICIPATES IN G Alpha (I) Signalling Events
Alpha-2C Adrenergic Receptor PARTICIPATES IN G Alpha (Z) Signalling Events
G Alpha (Q) Signalling Events POSITIVELY REGULATES Vasoconstriction
G Alpha (12/13) Signalling Events POSITIVELY REGULATES Vasoconstriction
G Alpha (I) Signalling Events POSITIVELY REGULATES Vasoconstriction
G Alpha (Z) Signalling Events POSITIVELY REGULATES Vasoconstriction
Vasoconstriction POSITIVELY CORRELATED WITH Vascular Diseases

Comment: MESH:D014652 was initially denoted as Disorder of blood vessel in the original xls file but the name on the MESH website, Vascular Diseases, is the one used here.

Reference: